FTIF Franklin Biotechnology Discovery Fd A (acc) SGD
PSPL Risk Classification: High
The Fund's investment objective is to seek capital appreciation. The Fund invests primarily in equity securities of biotechnology companies and discovery research firms located in the U.S. and other countries and to a lesser extent in debt securities of any type of foreign or U.S. issuers.
The Fund invests a substantial portion of its assets in smaller capitalization companies, which are generally companies with a market capitalization of less than USD 2 billion at the time of the Fund's investment.
Fund Information
- Asset Class:Equities
- Sector:Biotechnology
- Geography:Global
- Benchmark index:NASDAQ Biotechnology Index
- Launch Date:25 Oct 2007
- Launch Price:10
- Fund Currency:SGD
- Fund Source: CASH,SRS-IA
- CPF Risk Classification:
- Price Made Known On:T+2
- Price Type:Net Asset Value
- Dealing Cut Off Time:3:00PM Spore Time
Information
Cash | CPFOA-IA | CPFSA-IA | SRS-IA | |
---|---|---|---|---|
Minimum Investment Amount | SGD 1000 | - | - | SGD 1000 |
Minimum Subsequent Investment | SGD 500 | - | - | SGD 500 |
Minimum Redemption Amount ($)/units | 0 Unit(s) | - | - | 0 Unit(s) |
Relevant Charges
Cash | CPFOA-IA | CPFSA-IA | SRS-IA | |
---|---|---|---|---|
POEMS Sales Charge | 0% | - | - | 0% |
Internal Switch-in Charge/Min Switch-in Charge | 0.00 % / $ 0.00 | - | - | 0.00 % / $ 0.00 |
External Switch-in Charge | NA | - | - | NA |
Redemption/Realisation Charge | NA | - | - | NA |
Annual Management Fee | 1.5% | - | - | 1.5% |
Annual Trustee Fee | - | - | ||
Expense Ratio | 1.81% | - | - | 1.81% |
Fund Manager Sales Charge | NA | - | - | NA |
Admin Fee | NA | - | - | NA |